Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 9Gynecologic 2Genitourinary 2NET 1Gastrointestinal 1Endocrine 1Dermatologic 1Breast 1

Conditions

Colonic Neoplasms 3Colorectal Neoplasms 2Neoplasms 1Liver Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma 1

Interventions

Gemcitabine 69Fluorouracil 44pembrolizumab 43Oxaliplatin 42Capecitabine 40Bevacizumab 37Leucovorin 36Irinotecan 31Cisplatin 27Nivolumab 24Paclitaxel 21Cetuximab 21Panitumumab 20130-nm albumin-bound paclitaxel 20Sorafenib 18Albumin-Bound Paclitaxel 18Drug Therapy 15Docetaxel 15Cyclophosphamide 15Radiotherapy 14Blood Specimen Collection 14IFL protocol 12atezolizumab 11Exercise 11Taxes 10budigalimab 9Erlotinib Hydrochloride 9trametinib 8Folfox protocol 8Carboplatin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × epothilone B × Gastrointestinal × Clear all
NCT00035087 2013-12-04

EPO906 Therapy in Patients With Advanced Colorectal Cancer

Novartis

Phase 2 Completed
62 enrolled
Gastrointestinal

Carcinoma, Colonic Neoplasms, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡